We conducted the literature search on PubMed and Embase (Ovid) in December 2023 and updated it in June 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials
But its a tradeoff many people are willing to make when you look at the overall benefits that come with taking GLP-1s for weight loss. Advertisement Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more
Patch tests detecting sweat excretion of controlled substances are entirely unaffected by semaglutide use
The most common side effects of Semaglutide are mild intestinal issues, including nausea, vomiting, diarrhea, constipation, and stomach pain